These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


175 related items for PubMed ID: 16980044

  • 1. Hypoxia/reoxygenation up-regulated the expression of death receptor 5 and enhanced apoptosis in human hepatocyte line.
    Cao L, Li Y, Cheng F, Li S, Long D.
    Transplant Proc; 2006 Sep; 38(7):2207-9. PubMed ID: 16980044
    [Abstract] [Full Text] [Related]

  • 2. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
    Kim YH, Jung EM, Lee TJ, Kim SH, Choi YH, Park JW, Park JW, Choi KS, Kwon TK.
    Free Radic Biol Med; 2008 Mar 15; 44(6):1055-68. PubMed ID: 18164688
    [Abstract] [Full Text] [Related]

  • 3. Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells.
    Taniguchi H, Yoshida T, Horinaka M, Yasuda T, Goda AE, Konishi M, Wakada M, Kataoka K, Yoshikawa T, Sakai T.
    Cancer Res; 2008 Nov 01; 68(21):8918-27. PubMed ID: 18974136
    [Abstract] [Full Text] [Related]

  • 4. Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response.
    Jiang CC, Chen LH, Gillespie S, Kiejda KA, Mhaidat N, Wang YF, Thorne R, Zhang XD, Hersey P.
    Cancer Res; 2007 Jun 15; 67(12):5880-8. PubMed ID: 17575157
    [Abstract] [Full Text] [Related]

  • 5. [Relationship between death receptor 5 and apoptosis in hepatocellular carcinoma].
    Zhu RX, Lin JS, Song YH, Li PY, Tao LW.
    Zhonghua Zhong Liu Za Zhi; 2006 Apr 15; 28(4):261-4. PubMed ID: 16875623
    [Abstract] [Full Text] [Related]

  • 6. Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity.
    Ichikawa K, Liu W, Zhao L, Wang Z, Liu D, Ohtsuka T, Zhang H, Mountz JD, Koopman WJ, Kimberly RP, Zhou T.
    Nat Med; 2001 Aug 15; 7(8):954-60. PubMed ID: 11479629
    [Abstract] [Full Text] [Related]

  • 7. Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis.
    Taimr P, Higuchi H, Kocova E, Rippe RA, Friedman S, Gores GJ.
    Hepatology; 2003 Jan 15; 37(1):87-95. PubMed ID: 12500193
    [Abstract] [Full Text] [Related]

  • 8. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.
    Yasuda T, Yoshida T, Goda AE, Horinaka M, Yano K, Shiraishi T, Wakada M, Mizutani Y, Miki T, Sakai T.
    Mol Cancer Res; 2008 Dec 15; 6(12):1852-60. PubMed ID: 19074830
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis B virus core protein inhibits TRAIL-induced apoptosis of hepatocytes by blocking DR5 expression.
    Du J, Liang X, Liu Y, Qu Z, Gao L, Han L, Liu S, Cui M, Shi Y, Zhang Z, Yu L, Cao L, Ma C, Zhang L, Chen Y, Sun W.
    Cell Death Differ; 2009 Feb 15; 16(2):219-29. PubMed ID: 18927587
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hydrogen peroxide enhances TRAIL-induced cell death through up-regulation of DR5 in human astrocytic cells.
    Kwon D, Choi K, Choi C, Benveniste EN.
    Biochem Biophys Res Commun; 2008 Aug 08; 372(4):870-4. PubMed ID: 18534188
    [Abstract] [Full Text] [Related]

  • 12. Rottlerin induces apoptosis via death receptor 5 (DR5) upregulation through CHOP-dependent and PKC delta-independent mechanism in human malignant tumor cells.
    Lim JH, Park JW, Choi KS, Park YB, Kwon TK.
    Carcinogenesis; 2009 May 08; 30(5):729-36. PubMed ID: 19037087
    [Abstract] [Full Text] [Related]

  • 13. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation.
    Kim EH, Yoon MJ, Kim SU, Kwon TK, Sohn S, Choi KS.
    Cancer Res; 2008 Jan 01; 68(1):266-75. PubMed ID: 18172319
    [Abstract] [Full Text] [Related]

  • 14. Hepatocytes treated with HBV X protein as cytotoxic effectors kill primary hepatocytes by TNF-alpha-related apoptosis-induced ligand-mediated mechanism.
    Yang Y, Zheng L, Lv G, Jin X, Sheng J.
    Intervirology; 2007 Jan 01; 50(5):323-7. PubMed ID: 17657161
    [Abstract] [Full Text] [Related]

  • 15. [Effect of hypoxia/reoxygenation (H/R) on expression of MICA and MICB in human hepatocytes].
    He Y, Li YP, Li SF, Long D.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar 01; 36(2):157-60. PubMed ID: 15807254
    [Abstract] [Full Text] [Related]

  • 16. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
    Farrell GC, Larter CZ, Hou JY, Zhang RH, Yeh MM, Williams J, dela Pena A, Francisco R, Osvath SR, Brooling J, Teoh N, Sedger LM.
    J Gastroenterol Hepatol; 2009 Mar 01; 24(3):443-52. PubMed ID: 19226377
    [Abstract] [Full Text] [Related]

  • 17. Sp1 is involved in 8-chloro-adenosine-upregulated death receptor 5 expression in human hepatoma cells.
    Sun M, Zhang J, Liu S, Liu Y, Zheng D.
    Oncol Rep; 2008 Jan 01; 19(1):177-85. PubMed ID: 18097593
    [Abstract] [Full Text] [Related]

  • 18. Hypoxia/reoxygenation up-regulates death receptor expression and enhances apoptosis in human biliary epithelial cells.
    Feng L, Pang L, Guo Y, Ke N, Li S, Wei L, Li Q, Li Y.
    Life Sci; 2009 Aug 26; 85(9-10):401-7. PubMed ID: 19643115
    [Abstract] [Full Text] [Related]

  • 19. CAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction is a major component of SHetA2-induced apoptosis in lung cancer cells.
    Lin YD, Chen S, Yue P, Zou W, Benbrook DM, Liu S, Le TC, Berlin KD, Khuri FR, Sun SY.
    Cancer Res; 2008 Jul 01; 68(13):5335-44. PubMed ID: 18593935
    [Abstract] [Full Text] [Related]

  • 20. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells.
    Liu X, Yue P, Chen S, Hu L, Lonial S, Khuri FR, Sun SY.
    Cancer Res; 2007 May 15; 67(10):4981-8. PubMed ID: 17510429
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.